Jesse Ortendahl has a background in mathematics and statistics, and he has conducted disease simulation modeling for economic evaluations for over 15 years. At PHAR, Jesse conducts and oversees projects using quantitative and qualitative methodology, focusing primarily on cost-effectiveness and budget impact analyses, decision-analytic modeling, and health economics. His work at PHAR spans a range of clinical areas such as oncology, cardiology, pulmonology, mental health, and infectious diseases, among others. He was trained in health policy at the Harvard School of Public Health, with a focus on decision science. Jesse formerly served as a research analyst at the Center for Health Decision Science at the Harvard School of Public Health, conducting grant-funded research primarily on the cost effectiveness of different cervical cancer prevention strategies. He is an active member of the International Society for Pharmacoeconomics and Outcomes Research, and the Society for Medical Decision Making.